Tenaya Therapeutics, Inc. (TNYA) Presents at Jefferies Global Healthcare Conference 2026 Prepared Remarks Transcript
Tenaya Therapeutics, Inc. presented at the Jefferies Global Healthcare Conference 2026, highlighting its focus on heart disease therapies. CEO Faraz Ali discussed the company's mission to develop potentially curative treatments targeting the underlying causes of heart conditions. The presentation emphasized Tenaya's unique approach to addressing both rare and common forms of heart disease.
- ▪Tenaya Therapeutics, Inc. focuses on developing therapies for heart disease.
- ▪CEO Faraz Ali presented the company's vision at the Jefferies Global Healthcare Conference 2026.
- ▪The company aims to create potentially curative treatments for both rare and prevalent heart conditions.
Opening excerpt (first ~120 words) tap to expand
{"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage":{"@type":"WebPage","@id":"https://seekingalpha.com/article/4912506-tenaya-therapeutics-inc-tnya-presents-at-jefferies-global-healthcare-conference-2026-prepared"},"author":{"@type":"Person","name":"SA Transcripts","url":"https://seekingalpha.com/author/sa-transcripts"},"publisher":{"@context":"http://schema.org","@type":"Organization","address":{"@type":"PostalAddress","streetAddress":"244 5th Ave","addressLocality":"New York","addressRegion":"NY","postalCode":"10001","addressCountry":"US"},"alternateName":["SeekingAlpha","SA"],"brand":[{"@type":"Brand","name":"Seeking Alpha Premium","url":"https://seekingalpha.com/subscriptions/premium"},{"@type":"Brand","name":"Seeking Alpha…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Seeking Alpha.
Discussion
0 commentsMore from Seeking Alpha
